참고문헌
- Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
- Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
- Guo ST, Jiang CC, Wang GP, et al (2013). MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene, 32, 1910-20. https://doi.org/10.1038/onc.2012.214
- Hagman Z, Larne O, Edsjo A, et al (2010). miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer, 127, 2768-76. https://doi.org/10.1002/ijc.25269
- He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31. https://doi.org/10.1038/nrg1379
- Hsieh IS, Chang KC, Tsai YT, et al (2013). MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by down-regulating the Wnt/beta-catenin signaling pathway. Carcinogenesis, 34, 530-8. https://doi.org/10.1093/carcin/bgs371
- Kefas B, Godlewski J, Comeau L, et al (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res, 68, 3566-72. https://doi.org/10.1158/0008-5472.CAN-07-6639
- Li D, Zhao Y, Liu C, et al (2011). Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res, 17, 1722-30. https://doi.org/10.1158/1078-0432.CCR-10-1800
- Linsley PS, Schelter J, Burchard J, et al (2007). Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol, 27, 2240-52. https://doi.org/10.1128/MCB.02005-06
- Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Luo M, Shen D, Zhou X, Chen X, Wang W (2013). MicroRNA-497 is potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery, 12, 751-9.
- Porkka KP, Pfeiffer MJ, Waltering KK, et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5.. https://doi.org/10.1158/0008-5472.CAN-07-0533
- Ribas J, Ni X, Haffner M, et al (2009). miR-21: an androgen receptor-regulated microRNA that promotes hormonedependent and hormone-independent prostate cancer growth. Cancer Res, 69, 7165-9. https://doi.org/10.1158/0008-5472.CAN-09-1448
- Ru P, Steele R, Newhall P, et al (2012). miRNA-29b suppresses prostate cancer metastasis by regulating epithelialmesenchymal transition signaling. Mol Cancer Ther, 11, 1166-73. https://doi.org/10.1158/1535-7163.MCT-12-0100
- Shen L, Li J, Xu, L, et al (2012). miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med, 3, 475-80.
- Siegel R, Naishadham, D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Sun H, Li QW, Lv XY, et al (2010). MicroRNA-17 posttranscriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep, 37, 2951-8. https://doi.org/10.1007/s11033-009-9861-3
- Vasudevan S, Tong Y, Steitz JA (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931-4. https://doi.org/10.1126/science.1149460
- Watahiki A, Wang Y, Morris J, et al (2011). MicroRNAs associated with metastatic prostate cancer. PLoS One, 6, e24950. https://doi.org/10.1371/journal.pone.0024950
- Yadav S, Pandey A, Shukla A, et al (2011). miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem, 286, 37347-57. https://doi.org/10.1074/jbc.M111.235531
- BCL2 protein and cyclin D2. J Biol Chem, 286, 37347-57. Zhang J, Yang Y, Yang T, et al (2010). microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer, 103, 1215-20. https://doi.org/10.1038/sj.bjc.6605895
- Zheng D, Radziszewska A, Woo P (2012). MicroRNA 497 modulates interleukin 1 signalling via the MAPK/ERK pathway. FEBS Lett, 586, 4165-72. https://doi.org/10.1016/j.febslet.2012.10.014
- Zhu W, Zhu D, Lu S, et al (2012). miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol, 29, 384-91. https://doi.org/10.1007/s12032-010-9797-4
피인용 문헌
- Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia vol.390, pp.1-2, 2014, https://doi.org/10.1007/s11010-013-1958-2
- MicroRNA expression profiling in children with different asthma phenotypes vol.51, pp.6, 2015, https://doi.org/10.1002/ppul.23331
- MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility vol.13, pp.3, 2016, https://doi.org/10.3892/mmr.2016.4756
- Expression and function of microRNA-497 in human osteosarcoma vol.14, pp.1, 2016, https://doi.org/10.3892/mmr.2016.5256
- MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3 vol.36, pp.3, 2016, https://doi.org/10.3892/or.2016.4923
- Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101 vol.36, pp.4, 2016, https://doi.org/10.3892/or.2016.4980
- microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A vol.13, pp.6, 2017, https://doi.org/10.3892/ol.2017.6083
- MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3 vol.16, pp.5, 2017, https://doi.org/10.3892/mmr.2017.7345
- RETRACTED ARTICLE: Expression of microRNA-497 and its prognostic significance in human breast cancer vol.8, pp.1, 2013, https://doi.org/10.1186/1746-1596-8-172